{"id":529271,"date":"2021-02-08T16:02:01","date_gmt":"2021-02-08T16:02:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=529271"},"modified":"2021-02-08T16:02:01","modified_gmt":"2021-02-08T16:02:01","slug":"fragile-x-syndrome-overview-epidemiology-market-emerging-drugs-and-key-players","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/fragile-x-syndrome-overview-epidemiology-market-emerging-drugs-and-key-players_529271.html","title":{"rendered":"Fragile X Syndrome: Overview, Epidemiology, Market, Emerging Drugs and Key players"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1585648587.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Fragile X Syndrome: Overview, Epidemiology, Market, Emerging Drugs and Key players\" src=\"https:\/\/www.abnewswire.com\/uploads\/1585648587.jpeg\" alt=\"Fragile X Syndrome: Overview, Epidemiology, Market, Emerging Drugs and Key players\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>DelveInsight Business Research LLP      <\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight\u2019s \u2018Fragile X Syndrome (FXS) Market Insights, Epidemiology and Market Forecast\u20132030\u2019 report deliver an in-depth understanding of the Fragile X Syndrome (FXS), historical and forecasted epidemiology as well as the Fragile X Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/div>\n<p style=\"text-align: justify;\">Fragile X Syndrome (FXS) is a genetic disease due to a CGG trinucleotide expansion, named full mutation (greater than 200 CGG repeats), in the fragile X mental retardation 1 gene locus Xq27.3; which leads to an hyper-methylated region in the gene promoter therefore silencing it and lowering the expression levels of the fragile X mental retardation 1, a protein involved in synaptic plasticity and maturation.<\/p>\n<p style=\"text-align: justify;\"><strong>Fragile X Syndrome<\/strong><strong> Epidemiology Insights <\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The total cases of Fragile X Syndrome (FXS) in 7MM in 2017 were 117,962&nbsp;<\/li>\n<li>The diagnosed prevalent cases of Fragile X Syndrome in the United States in 2017 were 67,654<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>How will Disease transform <\/strong><strong>Fragile X Syndrome<\/strong><strong> Market?&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">According to DelveInsight<strong>, <\/strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/fragile-x-syndrome-fxs-market\"><strong>Fragile X Syndrome market size<\/strong><\/a> in 7MM in 2017 was USD 33.8 Million&nbsp;<\/p>\n<p style=\"text-align: justify;\"><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/uploads\/6660b5ee80ba2870d6d6143c0d888883.jpg\" alt=\"\" \/><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">The&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/fragile-x-syndrome-fxs-market\"><strong>FXS market outlook<\/strong><\/a>&nbsp;of the report helps to build a detailed comprehension of the historical, current and forecasted FXS market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers, and demand of better technology.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">This segment gives a thorough detail FXS market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria&rsquo;s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>To know more about Fragile X Syndrome Market, click here @&nbsp;<\/strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/fragile-x-syndrome-fxs-market\"><strong>https:\/\/www.delveinsight.com\/report-store\/fragile-x-syndrome-fxs-market<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\"><strong>Fragile X Syndrome Market Drivers<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Funding and cooperation of various organizations<\/li>\n<li>Identifying potential targets by animal models<\/li>\n<li>Development of novel therapies<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Fragile X Syndrome Market Barriers<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Failure of Clinical Trials<\/li>\n<li>Disease Burden<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>For more information on&nbsp;<\/strong><strong>Fragile X Syndrome Market trends, click here to get sample pages:-&nbsp;<\/strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/fragile-x-syndrome-fxs-market\"><strong>https:\/\/www.delveinsight.com\/sample-request\/fragile-x-syndrome-fxs-market<\/strong><\/a><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56407.html\" rel=\"nofollow\">DelveInsight<\/a><br \/><strong>Contact Person:<\/strong> Priya Maurya<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=fragile-x-syndrome-overview-epidemiology-market-emerging-drugs-and-key-players\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +919650213330<br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=fragile-x-syndrome-overview-epidemiology-market-emerging-drugs-and-key-players\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight Business Research LLP DelveInsight\u2019s \u2018Fragile X Syndrome (FXS) Market Insights, Epidemiology and Market Forecast\u20132030\u2019 report deliver an in-depth understanding of the Fragile X Syndrome (FXS), historical and forecasted epidemiology as well as the Fragile X Syndrome market trends in &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/fragile-x-syndrome-overview-epidemiology-market-emerging-drugs-and-key-players_529271.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[406,423,420,403,404],"tags":[],"class_list":["post-529271","post","type-post","status-publish","format-standard","hentry","category-Pharmaceuticals-Biotech","category-Professional-Services","category-Science","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/529271","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=529271"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/529271\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=529271"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=529271"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=529271"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}